DFAT has now concluded the evaluation process for the Product Development and Access Partnerships, in accordance with the process set out in the Application Guidelines. Following a highly competitive application process and an extensive review of proposals, DFAT has selected a portfolio of partnerships to proceed to the next phase of due diligence and agreement negotiations. DFAT is unable to provide individual feedback to unsuccessful applicants; however, feedback across all applications is available here (Word | PDF).
Successful applicants can find monitoring and evaluation resources here.
-------------------------
The availability of novel drugs, vaccines, diagnostics and vector control tools is critical for the fight against a range of high-burden infectious diseases, including drug-resistant strains.
Over the past 20 years, a number of global Product Development Partnerships (PDPs) have been established to foster the development of new global health products. PDPs work with research institutions, pharmaceutical companies and other actors to build a broad pipeline of priority products and take them through pre-clinical and clinical trials. PDPs have been successful in stewarding many products through to market authorisation. Access to new medical products for countries in our region relies not only on a well-funded research and development pipeline, but also requires safe and effective product introduction pathways, including rigorous regulatory assessment and affordable pricing. PDPs work closely with allied organisations to maximise the uptake of products emerging from their pipeline.
DFAT called for proposals from PDPs and allied organisations, focusing on products targeting infectious diseases of particular concern to the Pacific and Southeast Asia. This includes, for example, malaria, tuberculosis, dengue, sexually transmitted diseases (including HIV and HPV) and neglected tropical diseases such as scabies and trachoma. Proposals that address barriers to product access and utilisation in the Pacific and Southeast Asia, through engagement between product development partners and other institutions, are encouraged.
Offers and agreements will be initiated with successful applicants over the June – August 2023 period. Your patience as we work through the necessary processes is much appreciated.